Common Effexor side effects include drowsiness, nausea, and constipation
Figure
Describe the adverse effects associated with venlafaxine, including the FDA black-box warning
sweating sleepiness dry mouth digestive problems, such as nausea* constipation loss of appetite sweating on venlafaxine Posted 9 years ago, 33 users are following
Includes Effexor XR side effects, interactions and indications
It is also used to treat general anxiety disorder, social anxiety disorder, and panic disorder
excessive sweating; irregular bowel Excessive sweating—diaphoresis—affects up to 22% of patients who take antidepressants
Avoid or Use Alternate Drug
Antidepressant-induced excessive sweating: clinical features and Venlafaxine Regular/Immediate Release Venlafaxine Extended Release ; Tradename : Effexor IR : Effexor XR : Half-life : 5 hours : 13-14 hours : Dosage Strengths : 25 mg, 37
shivering
Side effects such as feeling sick, headaches, sweating, and dry mouth are common
, hallucinations, agitation, confusion) with propafenone initiation/dose increase
Venlafaxine is an SNRI antidepressant
; History of mania: The risk of developing mania may be increased while taking Effexor
Increased blood pressure can occur, and blood pressure should be monitored
If you are between the ages of 18 and 60, take no other medication or have no other medical conditions, side effects you are more likely to experience include: Nausea, headache, sedation, dry mouth, dizziness, insomnia, nervousness, constipation, and sweating
Common side effects, like drowsiness, nausea, and constipation, will often resolve with time
If you have problems with your liver or kidneys your doctor might prescribe a lower dose
Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide
dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr
My sweating would slowly decrease and the dizzy spells/brain zaps/sleep issues would die down after 2-3 weeks
Major Depressive Disorder - Adverse events in short-term studies that occurred in at least 5% of the patients receiving venlafaxine extended-release capsules and at a rate at least twice that of the placebo group were abnormal ejaculation, gastrointestinal complaints (nausea, dry mouth, and anorexia), CNS complaints (dizziness, somnolence